Gilead Sciences’ hepatitis drug patent faces legal challenge

International group representing doctors and patient have launched a fresh challenge to the patent on Gilead Sciences’ hepatitis C drug Sofosbuvir at the European patent office in order to increase access to treatment.  Sofosbuvir is sold by the US drugmaker as Sovaldi and is included in other hepatitis C medicine such as Harvoni and [...]

By |2017-09-08T10:51:55+05:30March 28th, 2017|Patent|0 Comments

Help C Drug Pricing: Sofosbuvir Unaffordable

Imagine waking up on the wrong side of the bed. Your skin looks yellow and you start feeling blue. Abdominal pains make you cringe, despite never having binged. The family doctor rules out jaundice and draws a blank. Your hospital-next-door churns out the blood report and you anxiously gaze into the diagnosis: “Tested positive [...]

By |2017-09-08T12:36:03+05:30March 7th, 2017|IP Basics|0 Comments
Go to Top